Anzeige
Mehr »
Sonntag, 10.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W15D | ISIN: US00182C1036 | Ticker-Symbol: BSFA
Tradegate
08.08.25 | 17:26
70,50 Euro
+0,71 % +0,50
1-Jahres-Chart
ANI PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ANI PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
69,0070,0009.08.
69,5070,0008.08.

Aktuelle News zur ANI PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
FrANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates2
FrH.C. Wainwright hebt Kursziel für ANI Pharmaceuticals auf 93 US-Dollar an1
FrANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright1
FrANI Pharmaceuticals übertrifft im Q2 2025 die Prognosen und hebt den Ausblick an - Aktie legt deutlich zu2
ANI PHARMACEUTICALS Aktie jetzt für 0€ handeln
FrANI PHARMACEUTICALS INC - 10-Q, Quarterly Report2
FrANI Pharmaceuticals beats top-line and bottom-line estimates; raises FY25 outlook1
FrANI PHARMACEUTICALS INC - 8-K, Current Report-
FrANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance154Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basisTotal Rare Disease quarterly net revenues of...
► Artikel lesen
DoANI Pharmaceuticals Q2 2025 Earnings Preview1
DoEarnings Preview For ANI Pharmaceuticals1
01.08.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET1
29.07.CG Oncology wins Delaware jury trial against ANI Pharmaceuticals2
24.07.ANI Pharmaceuticals stock holds steady as H.C. Wainwright maintains Buy rating2
23.07.ANI Pharma drops as clinical trial for eye implant fails against Regeneron's Eylea8
23.07.ANI Pharmaceuticals reports mixed results from NEW DAY trial for DME2
23.07.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN for Use in Patients with Diabetic Macular Edema (DME)109Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the aflibercept arm Study Enrolled Treatment-Naïve, or Almost Naïve, Patients with...
► Artikel lesen
23.07.ANI PHARMACEUTICALS INC - 8-K, Current Report-
11.07.ANI PHARMACEUTICALS INC - S-8, Securities to be offered to employees in employee benefit plans1
02.07.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th11
12.06.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces Presentation of New Preclinical Data1
Weiter >>
82 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1